The emerging approach of tirzepatide peptide represents a exciting advance in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – providing greater sugar control and anticipated red